The aims of this study were: (1) to determine which properties of a tumour mRNA marker decide if it is suitable for detection of tumour cells in tissues with an excess of immune cells, (2) to find tumour markers that would be complementary to CEA mRNA by improving sensitivity for the identification of disseminated tumour cells in lymph nodes of CRC patients and (3) to find a biomarker for tumour cells with metastasizing capacity. The gene discussed is CEACAM7; the disease is colorectal carcinoma.